Back to results
US 2012/0258102 A1Published application
Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibodies
AssigneeBiogen, Inc.
InventorAntonio J. Grillo-López
Life of this patent
Estimating the term…
Abstract
New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.
Claims5
A method for treating B-cell lymphoma comprising administering to a patient a therapeutically effective amount of anti-CD20 antibody before, during or subsequent to a chemotherapeutic regimen, wherein the chemotherapeutic regimen consists of CVP.
Dependencies are inferred from the claim text.